Vir Biotechnology

Price & Volume

Stats

52W Range	$4.15-$11.39
Market Cap	$843M
Shares Short	11M

Financials

Revenue (12 Mos)	$16.8M
Revenue Growth (YoY)	-89.9%
Gross Profit (12 Mos)	-$427.9M
Diluted EPS	-$3.62

News

Yahoo Finance • last month

Vir Biotechnology issues license to Norgine to market hepatitis D candidate

Yahoo Finance • last month

Is Alnylam Pharmaceuticals a Millionaire Maker?

Yahoo Finance • 2 months ago

Ability Biotherapeutics Expands its Scientific Advisory Board with the Appointment of Dr. John Burke and Dr. Alan Korman

Yahoo Finance • 2 months ago

Vir Biotechnology outlines accelerated hepatitis delta milestones and cash runway into mid-2027 as ECLIPSE 1 completes enrollment early

About

CEO	Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
CFO	Mr. Jason O'Byrne M.B.A.
Address	1800 Owens Street, San Francisco, CA, United States, 94158
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	408